Earnings History Data for Repligen Corporation (RGEN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Repligen Corporation

Repligen Corporation is a life sciences company focused on the development, production and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Their bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. They are a leading manufacturer of Protein A, a critical reagent used to separate and purify monoclonal antibody therapeutics. They also supply several growth factor products used to increase cell culture productivity during the fermentation stage of drug manufacturing. In addition, they have developed and marketed their OPUS? series of pre-packed `plug-and-play` chromatography columns, and they provide test kits to ensure final product quality. Aside from their core bioprocessing business, they have a portfolio of clinical-stage partnering assets, including a pancreatic imaging agent in Phase 3 development and an orphan drug candidate in Phase 1 development.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
21-02-2024 PM RGEN Repligen Corporation 11,640 0.33 0.33 0.68 Repligen misses top-line and bottom-line estimates; initiates FY24 outlook
[2/21/2024 7:33 AM]
194.16 -5.56 
(-2.79%)
185.00 -14.73 
(-7.37%)
110.45 - 211.13 1,070,490 570,000 34,620
31-10-2023 PM RGEN Repligen Corporation 6,830 0.23 0.14 0.77 Repligen beats top and bottom line estimates, narrows FY guidance
[10/31/2023 7:32 AM]
134.67 20.50 
(17.96%)
133.10 18.93 
(16.58%)
110.45 - 212.17 2,122,368 970,000 5,867
02-08-2023 PM RGEN Repligen Corporation 9,550 0.53 0.49 0.91 Repligen GAAP EPS of $0.53 beats by $0.21, revenue of $159.2M misses by $6.72M
[8/2/2023 7:34 AM]
170.65 3.53 
(2.11%)
165.00 -2.12 
(-1.27%)
134.64 - 262.26 1,058,961 760,000 16,742
02-05-2023 PM 7:30 AM ET
(May 2)
RGEN Repligen Corporation 8,080 0.64 0.59 0.92 Repligen Non-GAAP EPS of $0.64 beats by $0.05, revenue of $182.66M beats by $1.23M
[5/2/2023 7:36 AM]
157.03 3.49 
(2.27%)
156.67 3.13 
(2.04%)
137.21 - 262.26 988,166 770,000 15,935
22-02-2023 PM 7:30 AM ET
(Feb 22)
RGEN Repligen Corporation 11,000 0.68 0.58 0.81 Repligen Non-GAAP EPS of $0.68 beats by $0.10, revenue of $186.76M beats by $2.35M
[2/22/2023 7:34 AM]
170.12 -7.88 
(-4.43%)
186.90 8.90 
(5.00%)
137.21 - 262.26 1,858,427 440,000 511
01-11-2022 PM 7:30 AM ET
(Nov 1)
RGEN Repligen Corporation 10,100 0.77 0.68 0.78 Repligen reports Q3 earnings beat; updates FY22 guidance range above estimates
[11/1/2022 7:35 AM]
185.70 3.21 
(1.76%)
168.00 -14.49 
(-7.94%)
137.21 - 306.98 1,225,863 840,000 38,650
02-08-2022 PM 7:30 AM ET
(Aug 2)
RGEN Repligen Corporation 11,180 0.91 0.72 0.79 Repligen Non-GAAP EPS of $0.91 beats by $0.20, revenue of $207.63M beats by $18.57M
[8/2/2022 7:40 AM]
237.58 25.02 
(11.77%)
212.56 0.0 
(0.00%)
137.21 - 327.32 1,737,012 670,000 2,881
27-04-2022 PM 7:30 AM ET
(Apr 27)
RGEN Repligen Corporation 8,240 0.92 0.72 0.68 Repligen Non-GAAP EPS of $0.92 beats by $0.20, revenue of $206.4M beats by $20.92M; updates FY22 guidance
[4/27/2022 7:34 AM]
157.23 14.67 
(10.29%)
136.75 -5.81 
(-4.08%)
138.41 - 327.32 1,798,700 630,000 385
17-02-2022 PM 7:30 AM ET
(Feb 17)
RGEN Repligen Corporation 10,260 0.81 0.65 0.52 Repligen Non-GAAP EPS of $0.81 beats by $0.16, revenue of $186.52M beats by $8.25M
[2/17/2022 7:33 AM]
182.84 -1.20 
(-0.65%)
180.20 -3.83 
(-2.08%)
162.29 - 327.32 686,356 400,000 976
28-10-2021 PM 7:30 AM ET
(Oct 28)
RGEN Repligen Corporation 15,050 0.78 0.64 0.40 Repligen EPS beats by $0.30, beats on revenue
[10/28/2021 7:37 AM]
290.02 18.98 
(7.00%)
272.46 1.42 
(0.52%)
162.29 - 327.32 469,443 340,000 6,481
27-07-2021 PM 7:30 AM ET
(Jul 27)
RGEN Repligen Corporation 11,530 0.79 0.53 0.42 Repligen EPS beats by $0.27, beats on revenue
[7/27/2021 7:34 AM]
226.42 20.41 
(9.91%)
211.58 5.57 
(2.70%)
135.23 - 228.84 1,013,527 340,000 2,634
04-05-2021 PM 7:30 AM ET
(May 4)
RGEN Repligen Corporation 11,700 0.68 0.43 0.32 Repligen EPS beats by $0.25, beats on revenue; increases FY 2021 guidance
[5/4/2021 7:36 AM]
194.67 -13.44 
(-6.46%)
194.67 0.0 
(0.00%)
109.38 - 228.84 563,060 270,000 3,904
24-02-2021 PM 7:30 AM ET
(Feb 24)
RGEN Repligen Corporation 11,530 0.52 0.31 0.20 Repligen EPS beats by $0.21, beats on revenue
[2/24/2021 7:31 AM]
215.75 9.24 
(4.47%)
217.00 10.49 
(5.08%)
78.41 - 228.84 521,084 324,385 1,435
05-11-2020 PM 7:30 AM ET
(Nov 5)
RGEN Repligen Corporation 9,350 0.40 0.28 0.26 Repligen EPS beats by $0.11, beats on revenue
[11/5/2020 7:36 AM]
201.86 14.99 
(8.02%)
201.86 0.0 
(0.00%)
78.41 - 203.90 678,821 350,525 714
30-07-2020 PM 7:30 AM ET
(Jul 30)
RGEN Repligen Corporation 7,170 0.42 0.28 0.31 Repligen EPS beats by $0.14, beats on revenue
[7/30/2020 7:33 AM]
147.11 8.33 
(6.00%)
145.60 6.82 
(4.91%)
72.32 - 155.27 465,971 360,394 1,219
06-05-2020 PM RGEN Repligen Corporation 5,960 0.32 0.22 0.28 Repligen EPS beats by $0.07, beats on revenue
[5/6/2020 7:31 AM]
114.52 0.58 
(0.51%)
0.0 0.0 
(0.00%)
65.20 - 123.81 336,011 542,140 0